<DOC>
	<DOCNO>NCT01667575</DOCNO>
	<brief_summary>The purpose study observe efficacy ten day triple therapy-based , bismuth-containing quadruple therapy H.pylori treatment .</brief_summary>
	<brief_title>Efficiency Study Clarithromycin Bismuth-containing Quadruple Therapy Treat H.Pylori</brief_title>
	<detailed_description>The success rate currently recommend triple therapy proton pump inhibitor ( PPI ) plus amoxicillin clarithromycin fall unacceptable range . The purpose study observe efficacy ten day triple therapy-based , bismuth-containing quadruple therapy H.pylori treatment , ten day triple therapy use control .</detailed_description>
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Bismuth</mesh_term>
	<mesh_term>Potassium Citrate</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>patient present upper gastrointestinal symptom endoscopically proven H.pyloripositive functional dyspepsia scar peptic ulcer patient le 18 year old , history H. pylori infection treatment , previous gastric surgery , pregnancy , lactation , major systemic disease , administration antibiotic , bismuth , antisecretory drug precede 8 week , allergy one give medication regimen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>